Evidence map›Paper›PMID 29679680›Full record

ArticleNeuroscience letters2018

NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.

Roger L Papke, Can Peng, Ashok Kumar, Clare Stokes

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Modulation of CaScientific reports · 2024
    Article
  2. Review
  3. Review
  4. Review
  5. Stable desensitization of αEuropean journal of pharmacology · 2021
    Article
  6. Therapeutic Targeting ofPharmacological reviews · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. The Antinociceptive and Anti-Inflammatory Properties of theThe Journal of pharmacology and experimental therapeutics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Roger L PapkeDepartment of Pharmacology and Therapeutics, University of Florida, PO Box 100267, Gainesville, FL 32610, United States. Electronic address: rlpapke@ufl.edu.
Can PengDepartment of Pharmacology and Therapeutics, University of Florida, PO Box 100267, Gainesville, FL 32610, United States.
Ashok KumarDepartment of Neuroscience, University of Florida, PO Box 100244, Gainesville, FL 32610, United States.
Clare StokesDepartment of Pharmacology and Therapeutics, University of Florida, PO Box 100267, Gainesville, FL 32610, United States.
University of Florida · US

Funding

Targeting of Alpha7 nAChR for therapeutic effectsR01GM057481 · NIGMS · UNIVERSITY OF FLORIDA · PI PAPKE, ROGER L · 2000 to 2023
$7.6M
Use of viral-vectors for studying effects of chronic inflammation on executive functionR01AG052258 · NIA · UNIVERSITY OF FLORIDA · PI FOSTER, THOMAS C · 2016 to 2020
$1.9M
NIA NIH HHS R01 AG052258NIGMS NIH HHS R01 GM057481
6 · The paper itself

Abstract

Long-term potentiation (LTP) in the dentate gyrus was previously shown to be enhanced by nicotine, an effect dependent on both homomeric α7 and heteromeric α2β2 nicotinic acetylcholine receptors (nAChR). In our experiments, bath-applied nicotine produced no significant enhancement of LTP. The α7 nAChR silent agonist NS6740, a weak activator of α7 nAChR ion channels but an effective modulator of the cholinergic anti-inflammatory pathway, decreased LTP and, additionally, produced a substantial reduction in the baseline synaptic function prior to the high frequency stimulation used to induce LTP. The effects of NS6740 on the various ligand-gated ion channels associated with the generation and modulation of dentate LTP were evaluated with receptors expressed in Xenopus oocytes. A 60 s pre-application of 5 μM NS6740 to α7 receptors blocked the response to subsequent applications of acetylcholine (ACh). In contrast, the responses of α2β2 nAChR to control applications of ACh were not significantly affected by NS6740. Likewise, responses of cells expressing GluR1 + GluR2 AMPA-type glutamate receptor subunits or GABA

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsAzabicyclo CompoundsFuransHippocampusLong-Term PotentiationMaleNicotineNicotinic AgonistsRats, Sprague-DawleyXenopus1,4-diazabicyclo(3.2.2)nonan-4-yl(5-(3-(trifluoromethyl)phenyl)furan-2-yl)methanonealpha7 Nicotinic Acetylcholine ReceptorAzabicyclo CompoundsFuransNicotineNicotinic AgonistsDentate gyrusHippocampusLTPNicotinic acetylcholine receptorsNS6740PNU-120596α7 Signaling

Identifiers

PMID29679680
PMCPMC6191859
OpenAlexW2801933621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.